Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study compares muscle-balancing techniques for desk workers' neck and shoulder pain

NCT ID NCT07372391

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two treatments for upper cross syndrome, a common muscle imbalance from poor posture. Sixty adults with neck, shoulder, or upper back pain and fatigue took part. One group used Janda's approach (stretching tight muscles and strengthening weak ones), while the other used instrument-assisted soft tissue mobilization (IASTM) plus heat and TENS. The goal was to see which better reduced pain, fatigue, and improved posture.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jul 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 44 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants aged between 19-44 years (Adults), both genders * Pectoralis major and Upper trapezius tightness, Serratus anterior and Lower trapezius weakness * Forward Head Posture (developed within 6 weeks or more than 3 months) * Reported neck, upper back, or shoulder pain or discomfort * Pain 5 or above on NPRS for at least 3 months * Fatigue score of 4 or above on Fatigue Severity Scale Exclusion Criteria: * Congenital anomalies * Thoracic Outlet Syndrome * Inflammatory disorders * Headache due to any cause (migraine, disc bulge) * Postural defects (Torticollis, Scoliosis) * Malignancy * Fracture of cervical spine and clavicle

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Upper cross syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Biological and Applied Sciences, Lahore

    Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.